Antiplatelet and Statin Treatment Is Not Associated With Reduced Myocardial Infarction After High-Risk Vascular Procedures

Medical management (MM) with antiplatelet (AP) and statin therapy is recommended for most patients undergoing vascular surgery. We evaluated the preoperative use of these on postoperative myocardial infarction (MI) in patients undergoing high-risk procedures within the Vascular Quality Initiative (VQI).

Source: Journal of Vascular Surgery - November 21, 2014 Category: Surgery Authors: Randall R. DeMartino, Andrew W. Hoel, Adam W. Beck, John W. Hallett, Shipra Arya, Gilbert H. Upchurch, Jack L. Cronenwett, Philip P. Goodney Tags: Abstract from the Thirty-Ninth Annual Meeting of the Southern Association for Vascular Surgery Source Type: research